|
|
|
|
Safety and Efficacy of 2 mg Bulevirtide in Patients with Chronic HBV/HDV Co-Infection:
First Real-World Results
French Early Access Program
|
|
|
Victor de Lédinghen, Dominique Guyader, Sophie Métivier, Marie-Noëlle Hilleret, Hélène Fontaine, Bruno Roche, Nathalie Ganne-Carrié, Louis d'Alteroche, Véronique Loustaud-Ratti, Anne Gervais, Christiane Stern, Laurent Alric, Isabelle Fouchard-Hubert, Tarik Asselah, Karine Lacombe, Fabien Zoulim, Jérôme Dumortier, Anne Minello, Caroline Lascoux-Combe, Léon Muti, Isabelle Ollivier-Hourmand, Dominique Larrey, Vincent Leroy, Isabelle Rosa, Julie Chas, Frédéric Heluwaert, Patrick Borentain, Isabelle Archambeaud, Bernard Prouvost-Keller, Si Nafa Si Ahmed, Dominique Roulot
French collaborative study. Bordeaux, Rennes, Toulouse, Grenoble, Paris, Tours, Limoges, Angers, Lyon, Dijon, Clermont-Ferrand, Montpellier, Caen, Annecy, Marseille.
|
|
|
|
|
|
|